Archive · Business Recorder
Haleon Pakistan starts local manufacturing of Panadol 500mg tablets in Sindh
Haleon Pakistan Limited, formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited, has commenced manufacturing Panadol 500mg tablets at its Jamshoro facility, marking a shift towards in-house production of the popular pain relief medicine. The company, which is primarily engaged in the manufacturing, marketing, and sale of consumer healthcare and over-the-counter (OTC) health products, disclosed the development in a notice to the Pakistan Stock Exchange (PSX) on Friday. The development follows an investment of approximately $10 million (~PKR2.8 billion) announced in October 2023....
ZAZTEK archives the headline, summary and publication date so the story stays findable. The full article remains the publisher's. Read it at Business Recorder →